{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:31:02Z","timestamp":1788582662522,"version":"build-2803163510"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":81,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"PIIO-OSUCCC startup funding"},{"name":"Pelotonia Award"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-026-03754-x","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T03:37:00Z","timestamp":1773459420000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tumor immunogenicity shapes CNS immune niches and CD8\u207a T cell fate in glioblastoma"],"prefix":"10.1186","volume":"23","author":[{"given":"Suman","family":"Asalla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar Santiagonunez","family":"Ahumada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan E.","family":"Krull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Disha N.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivaan","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Wieland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Giglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Tedeschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"key":"3754_CR1","doi-asserted-by":"publisher","unstructured":"Ostrom QT, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015\u20132019. Neuro Oncol. 2022;24. https:\/\/doi.org\/10.1093\/neuonc\/noac202.","DOI":"10.1093\/neuonc\/noac202"},{"key":"3754_CR2","doi-asserted-by":"publisher","unstructured":"Lim M, Xia Y, Bettegowda C, Weller M. Current state of immunotherapy for glioblastoma. Nat Rev Clin Oncol. 2018;15. Preprint at https:\/\/doi.org\/10.1038\/s41571-018-0003-5.","DOI":"10.1038\/s41571-018-0003-5"},{"key":"3754_CR3","doi-asserted-by":"publisher","unstructured":"Medikonda R, Dunn G, Rahman M, Fecci P, Lim M. A review of glioblastoma immunotherapy. J Neuro-Oncol. 2021;151. Preprint at https:\/\/doi.org\/10.1007\/s11060-020-03448-1.","DOI":"10.1007\/s11060-020-03448-1"},{"key":"3754_CR4","doi-asserted-by":"publisher","unstructured":"Miyazaki T, Ishikawa E, Sugii N, Matsuda M. Therapeutic strategies for overcoming immunotherapy resistance mediated by immunosuppressive factors of the glioblastoma microenvironment. Cancers. 2020;12. Preprint at https:\/\/doi.org\/10.3390\/cancers12071960.","DOI":"10.3390\/cancers12071960"},{"key":"3754_CR5","doi-asserted-by":"publisher","unstructured":"Louveau A, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523. https:\/\/doi.org\/10.1038\/nature14432.","DOI":"10.1038\/nature14432"},{"key":"3754_CR6","doi-asserted-by":"publisher","unstructured":"Aspelund A, et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med. 2015;212. https:\/\/doi.org\/10.1084\/jem.20142290.","DOI":"10.1084\/jem.20142290"},{"key":"3754_CR7","doi-asserted-by":"publisher","unstructured":"Louveau A, Harris, TH, Kipnis J. Revisiting the concept of CNS immune privilege. Trends Immunol. 2016;36. https:\/\/doi.org\/10.1016\/j.it.2015.08.006.","DOI":"10.1016\/j.it.2015.08.006"},{"key":"3754_CR8","doi-asserted-by":"publisher","unstructured":"Kipnis J. Multifaceted interactions between adaptive immunity and the central nervous system. Science. 2016;353. Preprint at https:\/\/doi.org\/10.1126\/science.aag2638.","DOI":"10.1126\/science.aag2638"},{"key":"3754_CR9","doi-asserted-by":"publisher","unstructured":"Alves De Lima K, Rustenhoven J, Kipnis J. Meningeal immunity and its function in maintenance of the central nervous system in health and disease. Ann Rev Immunol. 2020;38. Preprint at https:\/\/doi.org\/10.1146\/annurev-immunol-102319-103410.","DOI":"10.1146\/annurev-immunol-102319-103410"},{"key":"3754_CR10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev-neuro-113023-103045","volume":"47","author":"AFM Salvador","year":"2024","unstructured":"Salvador AFM, Abduljawad N, Kipnis J. Meningeal lymphatics in central nervous system diseases. Annu Rev Neurosci. 2024;47:323\u201344. https:\/\/doi.org\/10.1146\/annurev-neuro-113023-103045.","journal-title":"Annu Rev Neurosci"},{"key":"3754_CR11","doi-asserted-by":"publisher","unstructured":"Rustenhoven J, et al. Functional characterization of the dural sinuses as a neuroimmune interface. Cell. 2021;184. https:\/\/doi.org\/10.1016\/j.cell.2020.12.040.","DOI":"10.1016\/j.cell.2020.12.040"},{"key":"3754_CR12","doi-asserted-by":"publisher","unstructured":"Da Mesquita S, et al. Functional aspects of meningeal lymphatics in ageing and Alzheimer\u2019s disease. Nature. 2018;560. https:\/\/doi.org\/10.1038\/s41586-018-0368-8.","DOI":"10.1038\/s41586-018-0368-8"},{"key":"3754_CR13","doi-asserted-by":"publisher","unstructured":"Song E, et al. VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours. Nature. 2020;577. https:\/\/doi.org\/10.1038\/s41586-019-1912-x.","DOI":"10.1038\/s41586-019-1912-x"},{"key":"3754_CR14","doi-asserted-by":"publisher","unstructured":"Engelhardt B, Ransohoff RM. The ins and outs of T-lymphocyte trafficking to the CNS: Anatomical sites and molecular mechanisms. Trends Immunol. 2005;26. Preprint at https:\/\/doi.org\/10.1016\/j.it.2005.07.004.","DOI":"10.1016\/j.it.2005.07.004"},{"key":"3754_CR15","doi-asserted-by":"publisher","unstructured":"Louveau A, et al. CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat Neurosci. 2018;21. https:\/\/doi.org\/10.1038\/s41593-018-0227-9.","DOI":"10.1038\/s41593-018-0227-9"},{"key":"3754_CR16","doi-asserted-by":"publisher","unstructured":"Rua R, McGavern DB. Advances in meningeal immunity. Trends Mol Med. 2018;24. Preprint at https:\/\/doi.org\/10.1016\/j.molmed.2018.04.003.","DOI":"10.1016\/j.molmed.2018.04.003"},{"key":"3754_CR17","doi-asserted-by":"publisher","unstructured":"Mrdjen D, et al. High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease. Immunity. 2018;48. https:\/\/doi.org\/10.1016\/j.immuni.2018.01.011.","DOI":"10.1016\/j.immuni.2018.01.011"},{"key":"3754_CR18","doi-asserted-by":"publisher","unstructured":"Pikor NB, Prat A, Bar-Or A, Gommerman JL. Meningeal tertiary lymphoid tissues and multiple sclerosis: a gathering place for diverse types of immune cells during CNS autoimmunity. Front Immunol. 2016;6. Preprint at https:\/\/doi.org\/10.3389\/fimmu.2015.00657.","DOI":"10.3389\/fimmu.2015.00657"},{"key":"3754_CR19","doi-asserted-by":"publisher","unstructured":"Helmink BA, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577. https:\/\/doi.org\/10.1038\/s41586-019-1922-8.","DOI":"10.1038\/s41586-019-1922-8"},{"key":"3754_CR20","doi-asserted-by":"publisher","unstructured":"Mitsdoerffer M, et al. Formation and immunomodulatory function of meningeal B cell aggregates in progressive CNS autoimmunity. Brain. 2021;144. https:\/\/doi.org\/10.1093\/brain\/awab093.","DOI":"10.1093\/brain\/awab093"},{"key":"3754_CR21","doi-asserted-by":"publisher","unstructured":"Mitsdoerffer M, Peters A. Tertiary lymphoid organs in central nervous system autoimmunity. Front Immunol. 2016;7. Preprint at https:\/\/doi.org\/10.3389\/fimmu.2016.00451.","DOI":"10.3389\/fimmu.2016.00451"},{"key":"3754_CR22","doi-asserted-by":"publisher","unstructured":"Saut\u00e8s-Fridman C, Petitprez F, Calderaro J, Fridman WH. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat Rev Cancer. 2019;19. Preprint at https:\/\/doi.org\/10.1038\/s41568-019-0144-6.","DOI":"10.1038\/s41568-019-0144-6"},{"key":"3754_CR23","doi-asserted-by":"publisher","unstructured":"Cabrita R, et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature. 2020;577. https:\/\/doi.org\/10.1038\/s41586-019-1914-8.","DOI":"10.1038\/s41586-019-1914-8"},{"key":"3754_CR24","doi-asserted-by":"publisher","unstructured":"Zou J, et al. Tertiary Lymphoid Structures: A Potential Biomarker for Anti-Cancer Therapy. Cancers. 2022;14. Preprint at https:\/\/doi.org\/10.3390\/cancers14235968.","DOI":"10.3390\/cancers14235968"},{"key":"3754_CR25","doi-asserted-by":"publisher","unstructured":"Zhang Q, Wu S. Tertiary lymphoid structures are critical for cancer prognosis and therapeutic response. Front Immunol. 2023;13. Preprint at https:\/\/doi.org\/10.3389\/fimmu.2022.1063711.","DOI":"10.3389\/fimmu.2022.1063711"},{"key":"3754_CR26","doi-asserted-by":"publisher","unstructured":"Tr\u00fcb M, Zippelius A. Tertiary lymphoid structures as a predictive biomarker of response to cancer immunotherapies. Front Immunol. 2021;12. Preprint at https:\/\/doi.org\/10.3389\/fimmu.2021.674565.","DOI":"10.3389\/fimmu.2021.674565"},{"key":"3754_CR27","doi-asserted-by":"publisher","unstructured":"Cakmak P, et al. Spatial immune profiling defines a subset of human gliomas with functional tertiary lymphoid structures. Immunity. 2025. https:\/\/doi.org\/10.1016\/j.immuni.2025.09.018.","DOI":"10.1016\/j.immuni.2025.09.018"},{"key":"3754_CR28","doi-asserted-by":"publisher","unstructured":"van de Walle T, et al. Tertiary lymphoid structures in the central nervous system: implications for glioblastoma. Front Immunol. 2021;12. Preprint at https:\/\/doi.org\/10.3389\/fimmu.2021.724739.","DOI":"10.3389\/fimmu.2021.724739"},{"key":"3754_CR29","doi-asserted-by":"publisher","unstructured":"Ramachandran M, et al. Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma. Cancer Cell. 2023;41. https:\/\/doi.org\/10.1016\/j.ccell.2023.04.010.","DOI":"10.1016\/j.ccell.2023.04.010"},{"key":"3754_CR30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nature19330","volume":"537","author":"SJ Im","year":"2016","unstructured":"Im SJ, et al. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy. Nature. 2016;537:417\u201321.","journal-title":"Nature"},{"key":"3754_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","volume":"50","author":"I Siddiqui","year":"2019","unstructured":"Siddiqui I, et al. Intratumoral Tcf1 + PD-1 + CD8 + T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy. Immunity. 2019;50:195-211.e10.","journal-title":"Immunity"},{"key":"3754_CR32","doi-asserted-by":"publisher","unstructured":"Utzschneider DT, et al. T Cell factor 1-expressing memory-like CD8+ T cells sustain the immune response to chronic viral infections. Immunity. 2016;45. https:\/\/doi.org\/10.1016\/j.immuni.2016.07.021.","DOI":"10.1016\/j.immuni.2016.07.021"},{"key":"3754_CR33","doi-asserted-by":"publisher","unstructured":"Hashimoto M, et al. CD8 T cell exhaustion in chronic infection and cancer: opportunities for interventions. Annu Rev Med. 2018;69. https:\/\/doi.org\/10.1146\/annurev-med-012017-043208.","DOI":"10.1146\/annurev-med-012017-043208"},{"key":"3754_CR34","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","volume":"175","author":"M Sade-Feldman","year":"2018","unstructured":"Sade-Feldman M, et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. Cell. 2018;175:998-1013.e20.","journal-title":"Cell"},{"key":"3754_CR35","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1324-y","volume":"571","author":"AC Scott","year":"2019","unstructured":"Scott AC, et al. TOX is a critical regulator of tumour-specific T cell differentiation. Nature. 2019;571:270\u20134.","journal-title":"Nature"},{"key":"3754_CR36","doi-asserted-by":"publisher","unstructured":"Bordon Y. TOX for tired T cells. Nat Rev Immunol. 2019;19. Preprint at https:\/\/doi.org\/10.1038\/s41577-019-0193-9.","DOI":"10.1038\/s41577-019-0193-9"},{"key":"3754_CR37","doi-asserted-by":"publisher","unstructured":"Khan O, et al. TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion. Nature. 2019;571. https:\/\/doi.org\/10.1038\/s41586-019-1325-x.","DOI":"10.1038\/s41586-019-1325-x"},{"key":"3754_CR38","doi-asserted-by":"publisher","unstructured":"Singer M, et al. A distinct gene module for dysfunction uncoupled from activation in tumor-infiltrating T cells. Cell. 2016;166. https:\/\/doi.org\/10.1016\/j.cell.2016.08.052.","DOI":"10.1016\/j.cell.2016.08.052"},{"key":"3754_CR39","doi-asserted-by":"publisher","unstructured":"Jadhav RR, et al. Epigenetic signature of PD-1+ TCF1+ CD8 T cells that act as resource cells during chronic viral infection and respond to PD-1 blockade. Proc Natl Acad Sci U S A. 2019;116. https:\/\/doi.org\/10.1073\/pnas.1903520116.","DOI":"10.1073\/pnas.1903520116"},{"key":"3754_CR40","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41593-020-00789-y","volume":"24","author":"AR Pombo Antunes","year":"2021","unstructured":"Pombo Antunes AR, et al. Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization. Nat Neurosci. 2021;24:595\u2013610.","journal-title":"Nat Neurosci"},{"key":"3754_CR41","doi-asserted-by":"publisher","unstructured":"Quail DF, Joyce JA. The Microenvironmental Landscape of Brain Tumors. Cancer Cell. 2017;31. Preprint at https:\/\/doi.org\/10.1016\/j.ccell.2017.02.009.","DOI":"10.1016\/j.ccell.2017.02.009"},{"key":"3754_CR42","doi-asserted-by":"publisher","unstructured":"Yan D, et al. Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas. Oncogene. 2017;36. https:\/\/doi.org\/10.1038\/onc.2017.261.","DOI":"10.1038\/onc.2017.261"},{"key":"3754_CR43","doi-asserted-by":"crossref","unstructured":"Quail DF, et al. The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas. Science (1979). 32016;52. http:\/\/dx.doi.org\/10.1126\/science.aad3018.","DOI":"10.1126\/science.aad3018"},{"key":"3754_CR44","doi-asserted-by":"publisher","unstructured":"De Leo A, Ugolini A, Veglia F. Myeloid cells in glioblastoma microenvironment. Cells. 2021;10. Preprint at https:\/\/doi.org\/10.3390\/cells10010018.","DOI":"10.3390\/cells10010018"},{"key":"3754_CR45","doi-asserted-by":"publisher","unstructured":"Khan F, et al. Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy. J Clin Invest. 2023;133. Preprint at https:\/\/doi.org\/10.1172\/JCI163446.","DOI":"10.1172\/JCI163446"},{"key":"3754_CR46","doi-asserted-by":"publisher","unstructured":"Khalsa JK, et al. Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types. Nat Commun. 2020;11. https:\/\/doi.org\/10.1038\/s41467-020-17704-5.","DOI":"10.1038\/s41467-020-17704-5"},{"key":"3754_CR47","doi-asserted-by":"publisher","unstructured":"Wouters R, Bevers S, Riva M, De Smet F, Coosemans A. Immunocompetent mouse models in the search for effective immunotherapy in glioblastoma. Cancers. 2021;13. Preprint at https:\/\/doi.org\/10.3390\/cancers13010019.","DOI":"10.3390\/cancers13010019"},{"key":"3754_CR48","doi-asserted-by":"publisher","unstructured":"Oh T, et al. Immunocompetent murine models for the study of glioblastoma immunotherapy. J Transl Med. 2014;12. Preprint at https:\/\/doi.org\/10.1186\/1479-5876-12-107.","DOI":"10.1186\/1479-5876-12-107"},{"key":"3754_CR49","doi-asserted-by":"publisher","unstructured":"van Hooren L, et al. Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma. Nat Commun. 2021;12. https:\/\/doi.org\/10.1038\/s41467-021-24347-7.","DOI":"10.1038\/s41467-021-24347-7"},{"key":"3754_CR50","doi-asserted-by":"publisher","unstructured":"Ahmadzadeh M, et al. Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood. 2009;114. https:\/\/doi.org\/10.1182\/blood-2008-12-195792.","DOI":"10.1182\/blood-2008-12-195792"},{"key":"3754_CR51","doi-asserted-by":"publisher","unstructured":"Trautmann L, et al. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med. 2006;12. https:\/\/doi.org\/10.1038\/nm1482.","DOI":"10.1038\/nm1482"},{"key":"3754_CR52","doi-asserted-by":"publisher","unstructured":"Wherry EJ, et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity. 2007;27. https:\/\/doi.org\/10.1016\/j.immuni.2007.09.006.","DOI":"10.1016\/j.immuni.2007.09.006"},{"key":"3754_CR53","doi-asserted-by":"publisher","unstructured":"Gros A, et al. PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors. J Clin Invest. 2014;124. https:\/\/doi.org\/10.1172\/JCI73639.","DOI":"10.1172\/JCI73639"},{"key":"3754_CR54","doi-asserted-by":"publisher","unstructured":"Jubel JM, Barbati ZR, Burger C, Wirtz DC, Schildberg FA. The Role of PD-1 in Acute and Chronic Infection. Front Immunol. 2020;11. Preprint at https:\/\/doi.org\/10.3389\/fimmu.2020.00487.","DOI":"10.3389\/fimmu.2020.00487"},{"key":"3754_CR55","doi-asserted-by":"publisher","unstructured":"Russell JH, Ley TJ. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol. 2002;20. Preprint at https:\/\/doi.org\/10.1146\/annurev.immunol.20.100201.131730.","DOI":"10.1146\/annurev.immunol.20.100201.131730"},{"key":"3754_CR56","doi-asserted-by":"publisher","unstructured":"Iorgulescu JB, et al. Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model. Front Immunol. 2023;14. https:\/\/doi.org\/10.3389\/fimmu.2023.1297932.","DOI":"10.3389\/fimmu.2023.1297932"},{"key":"3754_CR57","doi-asserted-by":"publisher","unstructured":"Treger RS, et al. The lupus susceptibility locus Sgp3 encodes the suppressor of endogenous retrovirus expression SNERV. Immunity. 2019;50. https:\/\/doi.org\/10.1016\/j.immuni.2018.12.022.","DOI":"10.1016\/j.immuni.2018.12.022"},{"key":"3754_CR58","doi-asserted-by":"publisher","unstructured":"Wolf Y, Anderson AC, Kuchroo VK. TIM3 comes of age as an inhibitory receptor. Nat Rev Immunol. 2020;20. Preprint at https:\/\/doi.org\/10.1038\/s41577-019-0224-6.","DOI":"10.1038\/s41577-019-0224-6"},{"key":"3754_CR59","doi-asserted-by":"publisher","unstructured":"Acharya N, Acharya N, Sabatos-Peyton C, Anderson AC, Anderson AC. Tim-3 finds its place in the cancer immunotherapy landscape. J ImmunoTher Cancer. 2020;8. Preprint at https:\/\/doi.org\/10.1136\/jitc-2020-000911.","DOI":"10.1136\/jitc-2020-000911"},{"key":"3754_CR60","doi-asserted-by":"publisher","unstructured":"Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015;15. Preprint at https:\/\/doi.org\/10.1038\/nri3862.","DOI":"10.1038\/nri3862"},{"key":"3754_CR61","doi-asserted-by":"publisher","unstructured":"Gupta PK, et al. CD39 Expression identifies terminally exhausted CD8+ T cells. PLoS Pathog. 2015;11. https:\/\/doi.org\/10.1371\/journal.ppat.1005177.","DOI":"10.1371\/journal.ppat.1005177"},{"key":"3754_CR62","doi-asserted-by":"publisher","unstructured":"Caldwell RW, Rodriguez PC, Toque HA, Priya Narayanan S, Caldwell RB. Arginase: A multifaceted enzyme important in health and disease. Physiol Rev. 2018;98. Preprint at https:\/\/doi.org\/10.1152\/physrev.00037.2016.","DOI":"10.1152\/physrev.00037.2016"},{"key":"3754_CR63","doi-asserted-by":"publisher","unstructured":"Szondi DC, Wong JK, Vardy LA, Cruickshank SM. Arginase Signalling as a Key Player in Chronic Wound Pathophysiology and Healing. Front Mol Biosci. 2021;8. Preprint at https:\/\/doi.org\/10.3389\/fmolb.2021.773866.","DOI":"10.3389\/fmolb.2021.773866"},{"key":"3754_CR64","doi-asserted-by":"publisher","unstructured":"Geiger R, et al. L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity. Cell. 2016;167. https:\/\/doi.org\/10.1016\/j.cell.2016.09.031.","DOI":"10.1016\/j.cell.2016.09.031"},{"key":"3754_CR65","doi-asserted-by":"publisher","unstructured":"Mastelic-Gavillet B, et al. Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells. J Immunother. Cancer. 2019;7. https:\/\/doi.org\/10.1186\/s40425-019-0719-5.","DOI":"10.1186\/s40425-019-0719-5"},{"key":"3754_CR66","doi-asserted-by":"publisher","unstructured":"Paolicelli RC, et al. Microglia states and nomenclature: A field at its crossroads. Neuron. 2022;110. Preprint at https:\/\/doi.org\/10.1016\/j.neuron.2022.10.020.","DOI":"10.1016\/j.neuron.2022.10.020"},{"key":"3754_CR67","doi-asserted-by":"publisher","unstructured":"Ransohoff RM, Engelhardt B. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol. 2012;12. Preprint at https:\/\/doi.org\/10.1038\/nri3265.","DOI":"10.1038\/nri3265"},{"key":"3754_CR68","doi-asserted-by":"publisher","unstructured":"Engelhardt B, Vajkoczy P, Weller RO. The movers and shapers in immune privilege of the CNS. Nat Immunol. 2017;18. Preprint at https:\/\/doi.org\/10.1038\/ni.3666.","DOI":"10.1038\/ni.3666"},{"key":"3754_CR69","doi-asserted-by":"publisher","unstructured":"Rua R, et al. Infection drives meningeal engraftment by inflammatory monocytes that impairs CNS immunity. Nat Immunol. 2019;20. https:\/\/doi.org\/10.1038\/s41590-019-0344-y.","DOI":"10.1038\/s41590-019-0344-y"},{"key":"3754_CR70","doi-asserted-by":"publisher","unstructured":"Wongthida P, et al. Ad-CD40L mobilizes CD4 T cells for the treatment of brainstem tumors. Neuro Oncol. 2020;22. https:\/\/doi.org\/10.1093\/neuonc\/noaa126.","DOI":"10.1093\/neuonc\/noaa126"},{"key":"3754_CR71","doi-asserted-by":"publisher","unstructured":"Cugurra A, et al. Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma. Science (1979). 2021;373. https:\/\/doi.org\/10.1126\/science.abf7844.","DOI":"10.1126\/science.abf7844"},{"key":"3754_CR72","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41586-023-06993-7","volume":"627","author":"LCD Smyth","year":"2024","unstructured":"Smyth LCD, et al. Identification of direct connections between the dura and the brain. Nature. 2024;627:165\u201373.","journal-title":"Nature"},{"key":"3754_CR73","doi-asserted-by":"publisher","unstructured":"Chour W, et al. Large libraries of single-chain trimer peptide-MHCs enable antigen-specific CD8+ T cell discovery and analysis. Commun Biol. 2023;6. https:\/\/doi.org\/10.1038\/s42003-023-04899-8.","DOI":"10.1038\/s42003-023-04899-8"},{"key":"3754_CR74","doi-asserted-by":"publisher","unstructured":"Waibl Polania J, et al. Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion. Immunity. 2024. https:\/\/doi.org\/10.1016\/j.immuni.2024.11.026.","DOI":"10.1016\/j.immuni.2024.11.026"},{"key":"3754_CR75","doi-asserted-by":"publisher","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9. https:\/\/doi.org\/10.1038\/nmeth.1923.","DOI":"10.1038\/nmeth.1923"},{"key":"3754_CR76","doi-asserted-by":"publisher","unstructured":"Li H, et al. The sequence alignment\/map format and SAMtools. Bioinformatics. 2009;25. https:\/\/doi.org\/10.1093\/bioinformatics\/btp352.","DOI":"10.1093\/bioinformatics\/btp352"},{"key":"3754_CR77","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing Preprint at. 2019. https:\/\/www.R-project.org\/."},{"key":"3754_CR78","doi-asserted-by":"publisher","unstructured":"Wickham H. Ggplot2: Elegant Graphics for Data Analysis. Springer-Verlag New York; 2016. Media vol. 35. https:\/\/doi.org\/10.1007\/978-3-319-24277-4_9.","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"3754_CR79","doi-asserted-by":"publisher","unstructured":"Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32. https:\/\/doi.org\/10.1093\/bioinformatics\/btw313.","DOI":"10.1093\/bioinformatics\/btw313"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03754-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03754-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03754-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:17:18Z","timestamp":1780453038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03754-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3754"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03754-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8225290\/v1","asserted-by":"object"}]},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by the Institutional Animal Care and Use Committee (IACUC) at The Ohio State University and were conducted in accordance with institutional guidelines and NIH standards for the care and use of laboratory animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This manuscript does not contain data from individual persons.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"185"}}